Baxdela (Melinta Therapeutics). Baxdela is an anionic fluoroquinolone antibiotic. The drug demonstrates in vitro and clinical activity against gram-positive and gram-negative pathogens, including methicillin-resistant Staphylococcus aureus.
| ← Previous | RETURN TO FULL LIST | Next → |
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
